We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Eva-Hip, Evaluation of Rehabilitation After Hip-fracture (Eva-Hip)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01379456
First Posted: June 23, 2011
Last Update Posted: September 22, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Trondheim Kommune
Norsk kvinners sanitetsforening
Information provided by (Responsible Party):
Norwegian University of Science and Technology
  Purpose
To evaluate the effect on gait and activity of a home based physiotherapy intervention 4-6 months after the fracture. The investigators hypothesis is that exercises performed after the initial rehabilitation, which focuses on specific components of gait control will improve gait and increase level of activity.

Condition Intervention
Hip Fracture Procedure: physiotherapy

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: The Effect on Gait and Activity Level of a Physiotherapy Intervention Aimed at Improving Mediolateral Stability 4 Months After a Hip Fracture

Resource links provided by NLM:


Further study details as provided by Norwegian University of Science and Technology:

Primary Outcome Measures:
  • change in gait speed [ Time Frame: 4,6 and 12 months postfracture ]

Secondary Outcome Measures:
  • change in activity level [ Time Frame: 4,6 and 12 month postfracture ]

Enrollment: 223
Actual Study Start Date: February 2011
Study Completion Date: June 2016
Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: physiotherapy
exercises
Procedure: physiotherapy
exercises, 20 sessions over 10 weeks
No Intervention: conventional treatment
care as usual

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   70 Years and older   (Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Home dwelling prior to fracture
  • age>70yr
  • able to walk 10m

Exclusion Criteria:

  • expected life expectancies <3 months
  • exercises contraindicated due to medical conditions
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01379456


Locations
Norway
Norwegian University of Science and Technology
Trondheim, Norway, 7006
Sponsors and Collaborators
Norwegian University of Science and Technology
Trondheim Kommune
Norsk kvinners sanitetsforening
Investigators
Principal Investigator: Olav Sletvold, MD,PHD Department of Neuroscience, Norwegian University of Science and Technology
  More Information

Publications:
Responsible Party: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT01379456     History of Changes
Other Study ID Numbers: REK 2010/3265-3
First Submitted: June 15, 2011
First Posted: June 23, 2011
Last Update Posted: September 22, 2017
Last Verified: September 2017

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Fractures, Bone
Hip Fractures
Wounds and Injuries
Femoral Fractures
Hip Injuries
Leg Injuries